Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06970925 · ClinicalTrials.gov registry record · Early Phase 1
Pilot Study Evaluating the Advantages of Sucrosomial® Iron Post-operative Supplementation vs Standard of Care After Cardiac Surgery
A Early Phase 1 study of Cardiac Surgery, sponsored by Englewood Hospital and Medical Center.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT06970925: Recruiting Early Phase 1 study of Cardiac Surgery, sponsored by Englewood Hospital and Medical Center.
NCT06970925 is a Early Phase 1 study of Cardiac Surgery that is actively recruiting participants, run by Englewood Hospital and Medical Center. The registered enrollment target is 40 participants, below the 743-participant average among 19 other Cardiac Surgery trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06970925, a Early Phase 1 study of Cardiac Surgery, is actively recruiting participants, sponsored by Englewood Hospital and Medical Center.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Primary objective: to evaluate the non-inferiority in terms of improvement of hemoglobin (Hg) levels within 30 days postoperatively between two proposed treatments. Secondary objective: to evaluate the financial costs associated with Sucrosomial® Iron treatment compared to Iron Sucrose (IV), while demonstrating non-inferiority in the improvement of hemoglobin levels, reduction in transfusion requirements, and reduction of hospital/ICU stay length
Primary Outcome
Delta change of hemoglobin levels assessed at T1 in Sucrosomial Iron group to demonstrate non-inferiority compared to the Standard of Care.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Sucrosomial Iron (SI)
Study Locations (1)
New Jersey
- Englewood Hospital - Englewood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-06-30 |
| Est. Completion | 2026-06-30 |
| Phase | Early Phase 1 |
What NCT06970925 shows while recruiting
NCT06970925 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 743-participant average among 19 other Cardiac Surgery trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Cardiac Surgery appearing as the primary indexed condition, and to 1 intervention - of which Sucrosomial Iron (SI) is the first listed.
NCT06970925 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT06970925 about?
NCT06970925 is a clinical study titled "Pilot Study Evaluating the Advantages of Sucrosomial® Iron Post-operative Supplementation vs Standard of Care After Cardiac Surgery". Primary objective: to evaluate the non-inferiority in terms of improvement of hemoglobin (Hg) levels within 30 days postoperatively between two proposed treatments. Secondary objective: to evaluate the financial costs associated with Sucrosomial® Iron treatment compared to Iron Sucrose (IV), while ...
What is the current status of trial NCT06970925?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 40 participants. The study started on 2025-06-30. Estimated completion is 2026-06-30.
What conditions does trial NCT06970925 study?
This clinical trial studies the following conditions: Cardiac Surgery.
What interventions are being tested in trial NCT06970925?
The interventions under investigation include: Sucrosomial Iron (SI) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06970925?
This trial is sponsored by Englewood Hospital and Medical Center, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06970925 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiac Surgery
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06970925's enrollment target sits among peer trials
40 18th of 19 higher than 2 of 19 other Cardiac Surgery trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiac Surgery trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
ESP/PIF for Sternotomy
ACTIVE NOT RECRUITING · Early Phase 1
-
Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery
RECRUITING · NA
-
Oral Methadone in Cardiac Surgery
RECRUITING · Phase 4
-
Cardiopulmonary Bypass Induced Red Blood Cell Lysis
RECRUITING
-
Assessing the Burden of Perioperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery
RECRUITING
-
Nitric Oxide for Reduced Intensive Support in Cardiac Surgery With Cardiopulmonary Bypass
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI